Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Acute and chronic effects of cisplatin therapy on renal magnesium homeostasis.

Ariceta G, Rodriguez-Soriano J, Vallo A, Navajas A.

Med Pediatr Oncol. 1997 Jan;28(1):35-40.

PMID:
8950334
2.

Cisplatin and hypomagnesemia.

Lajer H, Daugaard G.

Cancer Treat Rev. 1999 Feb;25(1):47-58. Review.

PMID:
10212589
3.

Renal toxicity of cancer chemotherapeutic agents in children: ifosfamide and cisplatin.

Jones DP, Chesney RW.

Curr Opin Pediatr. 1995 Apr;7(2):208-13. Review.

PMID:
7787938
4.

Cisplatin nephrotoxicity affects magnesium and calcium metabolism.

Goren MP.

Med Pediatr Oncol. 2003 Sep;41(3):186-9. Review.

PMID:
12868117
5.

Nephrotoxicity induced by cancer chemotherapy with special emphasis on cisplatin toxicity.

Ries F, Klastersky J.

Am J Kidney Dis. 1986 Nov;8(5):368-79. Review.

PMID:
3538860
6.

[The kidney in children under chemotherapy].

Cachat F, Guignard JP.

Rev Med Suisse Romande. 1996 Dec;116(12):985-93. Review. French.

PMID:
9026889
7.

Renal and electrolyte disturbances associated with cisplatin.

Blachley JD, Hill JB.

Ann Intern Med. 1981 Nov;95(5):628-32. Review.

PMID:
7027859
8.

Gitelman-like syndrome after cisplatin therapy: a case report and literature review.

Panichpisal K, Angulo-Pernett F, Selhi S, Nugent KM.

BMC Nephrol. 2006 May 24;7:10. Review.

9.

Cortical blindness as a manifestation of hypomagnesemia secondary to cisplatin therapy: case report and review of literature.

Al-Tweigeri T, Magliocco AM, DeCoteau JF.

Gynecol Oncol. 1999 Jan;72(1):120-2. Review.

PMID:
9889044
10.

Magnesium deficiency: pathophysiologic and clinical overview.

al-Ghamdi SM, Cameron EC, Sutton RA.

Am J Kidney Dis. 1994 Nov;24(5):737-52. Review.

PMID:
7977315
11.

Long-term complications of chemotherapy for germ cell tumours.

Chaudhary UB, Haldas JR.

Drugs. 2003;63(15):1565-77. Review.

PMID:
12887263
12.

Cisplatin nephrotoxicity.

Meyer KB, Madias NE.

Miner Electrolyte Metab. 1994;20(4):201-13. Review.

PMID:
7845323
13.

Magnesium metabolism in childhood.

Geven WB, Monnens LA, Willems JL.

Miner Electrolyte Metab. 1993;19(4-5):308-13. Review.

PMID:
8264518
14.

Tetany due to hypomagnesemia induced by cisplatin and doxorubicin treatment for synovial sarcoma.

Mune T, Yasuda K, Ishii M, Matsunaga T, Miura K.

Intern Med. 1993 May;32(5):434-7. Review.

15.

[Level of evidence for therapeutic drug monitoring of cisplatin].

Hulin A, Royer B, Chatelut E, Le Guellec C; Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique.

Therapie. 2010 May-Jun;65(3):151-5. doi: 10.2515/therapie/2010022. Epub 2010 Aug 11. Review. French.

PMID:
20699064
16.

[Magnesium homeostasis. Etiopathogeny, clinical diagnosis and treatment of hypomagnesaemia. A case study].

González EP, Santos F, Coto E.

Nefrologia. 2009;29(6):518-24. doi: 10.3265/Nefrologia.2009.29.6.5534.en.full. Review. Spanish.

17.

Cisplatin-induced renal toxicity magn…ified: role of magnesium deficiency in AKI onset.

Romani AM.

Am J Physiol Renal Physiol. 2015 Dec 15;309(12):F1005-6. doi: 10.1152/ajprenal.00212.2015. Epub 2015 Oct 28. Review. No abstract available.

18.

Magnesium homeostasis and hypomagnesemia in children with malignancy.

Kaplinsky C, Alon US.

Pediatr Blood Cancer. 2013 May;60(5):734-40. doi: 10.1002/pbc.24460. Epub 2013 Jan 9. Review.

PMID:
23303583
19.

Cisplatin-induced hypomagnesemia with seizures: a case report and review of the literature.

Bellin SL, Selim M.

Gynecol Oncol. 1988 May;30(1):104-13. Review. No abstract available.

PMID:
3284791
20.

Cardiac arrhythmias after cisplatin infusion: three case reports and a review of the literature.

Tassinari D, Sartori S, Drudi G, Panzini I, Gianni L, Pasquini E, Abbasciano V, Ravaioli A, Iorio D.

Ann Oncol. 1997 Dec;8(12):1263-7. Review. No abstract available.

PMID:
9496393

Supplemental Content

Support Center